306 related articles for article (PubMed ID: 18950730)
1. Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles.
Stiles BL
Int J Biochem Cell Biol; 2009 Apr; 41(4):757-61. PubMed ID: 18950730
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting PTEN.
Rosivatz E
Biochem Soc Trans; 2007 Apr; 35(Pt 2):257-9. PubMed ID: 17371253
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade.
Liu JL; Mao Z; LaFortune TA; Alonso MM; Gallick GE; Fueyo J; Yung WK
Cancer Res; 2007 Nov; 67(22):11054-63. PubMed ID: 18006852
[TBL] [Abstract][Full Text] [Related]
4. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
[TBL] [Abstract][Full Text] [Related]
5. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
[TBL] [Abstract][Full Text] [Related]
6. PI(3)king apart PTEN's role in cancer.
Zhang S; Yu D
Clin Cancer Res; 2010 Sep; 16(17):4325-30. PubMed ID: 20622047
[TBL] [Abstract][Full Text] [Related]
7. The protein-protein interaction-mediated inactivation of PTEN.
De Melo J; He L; Tang D
Curr Mol Med; 2014 Jan; 14(1):22-33. PubMed ID: 24236460
[TBL] [Abstract][Full Text] [Related]
8. Regulation and modulation of PTEN activity.
Naderali E; Khaki AA; Rad JS; Ali-Hemmati A; Rahmati M; Charoudeh HN
Mol Biol Rep; 2018 Dec; 45(6):2869-2881. PubMed ID: 30145641
[TBL] [Abstract][Full Text] [Related]
9. PTEN in Autism and Neurodevelopmental Disorders.
Rademacher S; Eickholt BJ
Cold Spring Harb Perspect Med; 2019 Nov; 9(11):. PubMed ID: 31427284
[TBL] [Abstract][Full Text] [Related]
10. Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition.
Lee JY; Kang MB; Jang SH; Qian T; Kim HJ; Kim CH; Kim Y; Kong G
Oncogene; 2009 Feb; 28(6):824-31. PubMed ID: 19079342
[TBL] [Abstract][Full Text] [Related]
11. PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity.
Tibarewal P; Zilidis G; Spinelli L; Schurch N; Maccario H; Gray A; Perera NM; Davidson L; Barton GJ; Leslie NR
Sci Signal; 2012 Feb; 5(213):ra18. PubMed ID: 22375056
[TBL] [Abstract][Full Text] [Related]
12. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
13. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
14. PTEN regulates phospholipase D and phospholipase C.
Alvarez-Breckenridge CA; Waite KA; Eng C
Hum Mol Genet; 2007 May; 16(10):1157-63. PubMed ID: 17405772
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
16. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.
Steelman LS; Abrams SL; Whelan J; Bertrand FE; Ludwig DE; Bäsecke J; Libra M; Stivala F; Milella M; Tafuri A; Lunghi P; Bonati A; Martelli AM; McCubrey JA
Leukemia; 2008 Apr; 22(4):686-707. PubMed ID: 18337767
[TBL] [Abstract][Full Text] [Related]
17. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
18. P-REX2a driving tumorigenesis by PTEN inhibition.
Leslie NR
Sci Signal; 2009 Oct; 2(94):pe68. PubMed ID: 19861688
[TBL] [Abstract][Full Text] [Related]
19. A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth.
Denning G; Jean-Joseph B; Prince C; Durden DL; Vogt PK
Oncogene; 2007 Jun; 26(27):3930-40. PubMed ID: 17213812
[TBL] [Abstract][Full Text] [Related]
20. Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers.
Langdon CG
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830628
[No Abstract] [Full Text] [Related]
[Next] [New Search]
